# JBIO (Jade Biosciences, Inc.) - SEC EDGAR Financial Statements

> Jade Biosciences, Inc. reported $486.4M in total assets and a net loss of $163.1M through December 31, 2025 from SEC EDGAR filings.

- Canonical: https://convexityos.com/fundamentals/JBIO
- Markdown: https://convexityos.com/fundamentals/JBIO.md
- SEC CIK: 0001798749
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 20, 2026, 05:30 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001798749&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | FY 2025 | -- | Dec 31, 2025 |
| Operating Income | FY 2025 | -$177.0M | Operating profit |
| Net Income | FY 2025 | -$163.1M | GAAP bottom line |
| Diluted EPS | FY 2025 | -$2.27 | Split-adjusted |
| Free Cash Flow | FY 2025 | -$94.89M | Operating CF less CapEx |
| Cash & ST Investments | Sep 30, 2026 | $475.7M | Total debt: $733K |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- | --- | --- |
| Research & Development | $93.12M | $53.19M | $64.22M | $38.62M | $14.99M | $7.94M |
| Total Operating Expenses | $113.5M | $74.60M | $81.41M | $53.24M | $23.02M | $8.89M |
| **Operating Income** | -$113.5M | -$74.60M | -$81.41M | -$53.24M | -$23.02M | -$8.89M |
| **EBITDA** | -$113.5M | -$74.31M | -$81.31M | -$53.17M | -$23.01M | -$8.89M |
| Interest Expense | -- | -- | -- | -- | -- | $75K |
| Income Before Tax | -$127.4M | -$69.57M | -$75.47M | -$51.49M | -$22.96M | -$9.61M |
| Income Tax Expense | $58K | $55K | $56K | $25K | $3.0K | -- |
| **Net Income** | -$127.4M | -$69.63M | -$75.52M | -$51.51M | -$22.96M | -$9.61M |
| Basic EPS | -$3.19 | -$22.32 | -$26.26 | -$19.21 | -$17.11 | -$368.80 |
| **Diluted EPS** | -$3.19 | -$22.32 | -$26.26 | -$19.21 | -$17.11 | -$368.80 |
| Basic Shares Outstanding | 31.4M | 3.1M | 2.9M | 2.7M | 1.3M | 26.5K |
| Diluted Shares Outstanding | 31.4M | 3.1M | 2.9M | 2.7M | 1.3M | 26.5K |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Research & Development | $30.82M | $50.06M | $36.05M | $28.54M | $22.01M | $22.55M | $20.02M | $1.53M |
| Total Operating Expenses | $39.64M | $58.92M | $43.45M | $34.98M | $27.40M | $27.78M | $23.38M | $6.40M |
| **Operating Income** | -$39.64M | -$58.92M | -$43.45M | -$34.98M | -$27.40M | -$27.78M | -$23.38M | -$6.40M |
| **EBITDA** | -$39.62M | -$58.91M | -$43.44M | -$34.97M | -$27.39M | -$27.78M | -$23.38M | -$6.39M |
| Income Before Tax | -$35.05M | -$55.75M | -$40.35M | -$31.87M | -$25.18M | -$32.13M | -$38.17M | -- |
| Income Tax Expense | $10K | $15K | $16K | -- | $0 | $0 | -- | $0 |
| **Net Income** | -$35.05M | -$55.77M | -$40.37M | -$31.93M | -$25.18M | -$32.13M | -$38.17M | -$5.43M |
| Basic EPS | -$0.42 | -$0.76 | -$0.57 | -- | -$0.48 | -$0.86 | -$12.10 | -- |
| **Diluted EPS** | -$0.42 | -$0.76 | -$0.57 | -- | -$0.48 | -$0.86 | -$12.10 | -- |
| Basic Shares Outstanding | 71.8M | 61.1M | 57.8M | -- | 39.6M | 28.4M | 3.2M | -- |
| Diluted Shares Outstanding | 71.8M | 61.1M | 57.8M | -- | 39.6M | 28.4M | 3.2M | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $88.44M | $69.39M | $23.49M | $22.40M | $54.20M | $4.57M |
| Short-Term Investments | $247.7M | $0 | $98.95M | $106.8M | $113.2M | -- |
| **Cash & Short-Term Investments** | $336.2M | $78.60M | $122.4M | $129.2M | $167.4M | $4.57M |
| **Total Current Assets** | $348.8M | $69.65M | $124.2M | $131.5M | $174.3M | $4.68M |
| Property, Plant & Equipment, Net | $170K | $0 | $288K | $242K | $186K | $39K |
| Other Non-Current Assets | $69K | $3.15M | $2.28M | $2.56M | $302K | -- |
| **Total Non-Current Assets** | $965K | $3.15M | $3.19M | $3.81M | $1.03M | $39K |
| **Total Assets** | $349.8M | $72.80M | $127.4M | $135.3M | $175.4M | $4.71M |
| Accounts Payable | $2.15M | $1.29M | $2.40M | $2.58M | $1.21M | $618K |
| Other Current Liabilities | -- | -- | -- | -- | -- | $18K |
| **Total Current Liabilities** | $16.54M | $12.00M | $17.64M | $7.78M | $2.55M | $1.77M |
| **Total Non-Current Liabilities** | $724K | $107.6M | $325K | $776K | $395K | $0 |
| **Total Liabilities** | $17.26M | $119.6M | $17.96M | $8.56M | $2.94M | $1.77M |
| **Total Debt (incl. Leases)** | $851K | $417K | $675K | $1.09M | $574K | -- |
| Common Stock | $5.0K | $1.0K | $3.0K | $2.0K | $2.0K | -- |
| Retained Earnings | -$174.4M | -$46.98M | -$163.4M | -$87.90M | -$36.39M | -$13.41M |
| Accumulated Other Comp. Income | $129K | $0 | $237K | -$466K | -$59K | -- |
| **Total Stockholders' Equity** | $332.5M | -$46.80M | $109.5M | $126.7M | $172.4M | -$13.34M |
| Total Equity | $332.5M | -$46.80M | $109.5M | $126.7M | $172.4M | -$13.34M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $80.39M | $107.2M | $55.09M | $88.44M | $50.11M | $220.9M | $44.22M | $69.39M |
| Short-Term Investments | $395.3M | $354.0M | $256.2M | $247.7M | $148.8M | -- | $31.99M | $0 |
| **Cash & Short-Term Investments** | $475.7M | $461.2M | $311.3M | $336.2M | $198.9M | $220.9M | $76.20M | $78.60M |
| **Total Current Assets** | $485.6M | $471.3M | $318.5M | $348.8M | $201.4M | $223.0M | $77.37M | $69.65M |
| Property, Plant & Equipment, Net | $136K | $144K | $157K | $170K | $176K | $147K | $2.0K | $0 |
| Other Non-Current Assets | $69K | $69K | $69K | $69K | $174K | $60K | -- | $3.15M |
| **Total Non-Current Assets** | $830K | $862K | $916K | $965K | $1.09M | $984K | $160K | $3.15M |
| **Total Assets** | $486.4M | $472.1M | $319.4M | $349.8M | $202.4M | $224.0M | $77.53M | $72.80M |
| Accounts Payable | $3.02M | $6.58M | $3.98M | $2.15M | $1.35M | $7.59M | $69K | $1.29M |
| **Total Current Liabilities** | $30.29M | $31.57M | $22.29M | $16.54M | $22.36M | $21.62M | $2.42M | $12.00M |
| **Total Non-Current Liabilities** | $594K | $628K | $679K | $724K | $747K | $792K | $70K | $107.6M |
| **Total Liabilities** | $30.89M | $32.20M | $22.97M | $17.26M | $23.10M | $22.41M | $2.49M | $119.6M |
| **Total Debt (incl. Leases)** | $733K | $761K | $808K | $851K | $867K | $811K | $312K | $417K |
| Common Stock | $7.0K | $6.0K | $5.0K | $5.0K | $3.0K | $3.0K | $3.0K | $1.0K |
| Retained Earnings | -$305.6M | -$270.5M | -$214.8M | -$174.4M | -$142.5M | -$117.3M | -$235.6M | -$46.98M |
| Accumulated Other Comp. Income | -$2.07M | -$660K | -$342K | $129K | $29K | -$24K | $50K | $0 |
| **Total Stockholders' Equity** | $455.5M | $439.9M | $296.5M | $332.5M | $179.3M | $201.6M | -$83.51M | -$46.80M |
| Total Equity | $455.5M | $439.9M | $296.5M | $332.5M | $179.3M | $201.6M | -$83.51M | -$46.80M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$127.4M | -$69.63M | -$75.52M | -$51.51M | -$22.96M | -$9.61M |
| Depreciation & Amortization | $26K | $282K | $96K | $68K | $15K | $1.0K |
| Stock-Based Compensation | $20.01M | $11.31M | $11.91M | $5.48M | $2.04M | $58K |
| Change in Payables | $361K | -$2.17M | -$164K | $1.37M | $609K | $37K |
| **Operating Cash Flow** | -$94.69M | -$71.20M | -$56.78M | -$39.12M | -$27.40M | -$7.86M |
| Capital Expenditure | -$196K | -- | -$142K | -$195K | -$181K | -- |
| **Free Cash Flow** | -$94.89M | -- | -$56.92M | -$39.32M | -$27.58M | -- |
| Purchases of Investments | -$261.2M | -- | -- | -- | -$113.3M | -- |
| Sales & Maturities of Investments | $14.41M | -- | -- | -- | -- | -- |
| **Investing Cash Flow** | -$247.0M | $56.03M | $11.88M | $6.93M | -$113.4M | -- |
| Common Stock Issued | -- | $23.94M | $44.89M | -- | $126.9M | -- |
| **Financing Cash Flow** | $360.8M | $25.43M | $46.00M | $396K | $190.5M | $8.92M |
| **Net Change in Cash** | $19.05M | $10.26M | $1.09M | -$31.80M | $49.62M | $1.06M |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$35.05M | -$55.77M | -$40.37M | -$31.93M | -$25.18M | -$32.13M | -$38.17M | -$5.43M |
| Depreciation & Amortization | $16K | $9.0K | $9.0K | $9.0K | $12K | $1.0K | $4.0K | $8.0K |
| Stock-Based Compensation | $7.07M | $13.61M | $7.41M | $9.40M | $4.29M | $3.90M | $2.42M | $1.24M |
| Change in Payables | -$3.05M | $2.10M | $2.33M | $301K | -$4.88M | $2.26M | $2.68M | -$684K |
| **Operating Cash Flow** | -$28.91M | -$43.66M | -$24.08M | -$33.65M | -$22.12M | -$20.16M | -$18.76M | -$11.05M |
| Purchases of Investments | -$74.93M | -$142.3M | -$73.90M | -- | -- | -- | -- | -- |
| Sales & Maturities of Investments | $32.63M | $44.69M | $65.43M | -- | -- | -- | -- | -- |
| **Investing Cash Flow** | -$42.30M | -$97.63M | -$8.47M | -$98.16M | -$148.7M | -$12.99M | $12.85M | $13.13M |
| **Financing Cash Flow** | $44.35M | $193.5M | -$795K | $170.2M | $0 | $191.3M | -$700K | $554K |
| **Net Change in Cash** | -$26.86M | $52.16M | -$33.35M | $38.33M | -$170.8M | $171.0M | -$19.46M | $2.64M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- | --- | --- |
| Return on Equity (ROE) | -38.3% | -- | -69.0% | -40.6% | -13.3% | -- |
| Return on Assets (ROA) | -36.4% | -95.6% | -59.3% | -38.1% | -13.1% | -203.8% |
| Current Ratio | 21.09x | 5.81x | 7.04x | 16.90x | 68.37x | 2.64x |
| Quick Ratio | 20.33x | 6.55x | 6.94x | 16.60x | 65.65x | 2.58x |
| Debt to Equity | 0.00x | -- | 0.01x | 0.01x | 0.00x | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Return on Equity (ROE) | -35.8% | -34.8% | -43.7% | -38.3% | -56.3% | -45.9% | -- | -- |
| Return on Assets (ROA) | -33.5% | -32.5% | -40.6% | -36.4% | -49.8% | -41.3% | -109.9% | -96.5% |
| Current Ratio | 16.03x | 14.93x | 14.29x | 21.09x | 9.01x | 10.31x | 32.01x | 5.81x |
| Quick Ratio | 15.70x | 14.61x | 13.96x | 20.33x | 8.90x | 10.22x | 31.53x | 6.55x |
| Debt to Equity | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | -- | -- |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
